TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA

Clinical trials for TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA explained in plain language.

Never miss a new study

Get alerted when new TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA trials appear

Sign up with your email to follow new studies for TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Pill aims to free patients from constant blood transfusions

Disease control Ongoing

This Phase 3 trial tested whether an oral medication called mitapivat could reduce the need for regular blood transfusions in adults with severe forms of thalassemia. 258 participants who required frequent transfusions were randomly assigned to receive either mitapivat or a place…

Matched conditions: TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA

Phase: PHASE3 • Sponsor: Agios Pharmaceuticals, Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA

Get alerted when new TRANSFUSION-DEPENDENT ALPHA-THALASSEMIA trials appear

Pill aims to free patients from constant blood transfusions